Kevin Waters compensation by year
PROCEPT BioRobotics Summary Compensation Table · all 6 fiscal years held| Component | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Salary | $388,130 | $388,130 | $415,000 | $448,750 | $482,500 | $502,250 |
| Bonus | $22,000 | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $0 | $0 | $276,911 | $974,181 | $1,112,019 | $1,480,761 |
| Option awards | $169,626 | $309,169 | $301,294 | $1,011,015 | $311,869 | $503,594 |
| Non-equity incentive | $155,252 | $155,252 | $329,100 | $225,360 | $275,600 | $256,148 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $0 | $0 | $0 | $6,000 | $6,000 | $7,500 |
| Total | $735,008 | $852,551 | $1,322,305 | $2,665,306 | $2,187,988 | $2,750,253 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PROCEPT BioRobotics Corp DEF 14A filed April 22, 2026, accession 0001588978-26-000017, and prior-year filings. Open the filing on EDGAR.
How this page was built: the PROCEPT BioRobotics Corp filed document, accession 0001588978-26-000017. Every figure is read from that document and cited to the page and table it appears in. Filed April 22, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 16,290 | $512,483 | — |
| RSU | 13,158 | $413,951 | — |
| RSU | 9,957 | $313,247 | — |
| PSU | 6,637 | $208,800 | — |
| RSU | 2,697 | $84,848 | — |
| PSU | 2,036 | $64,053 | — |
| RSU | 1,979 | $62,259 | — |
| Option | 6,505 | — | $47.17 |
| Option | 1,002 | — | $34.99 |
| Option | 14,917 | — | $37.02 |
Per the Outstanding Equity Awards at Fiscal Year-End table in PROCEPT BioRobotics Corp's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
4 Form 4 lines since the FY2025 proxy (filed April 22, 2026)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-09-09 | Sale | — | 373 | $20.95 | 180,355 |
| 2026-08-13 | Grant or award | — | 29,527 | $0.00 | 180,728 |
| 2026-08-13 | Grant or award derivative | — | 40,851 | $0.00 | 40,851 |
| 2026-06-08 | Sale | — | 357 | $28.48 | 151,201 |
The 4 most recent of 4 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments PROCEPT BioRobotics discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Involuntary termination without cause | $504,700 | $0 | $44,302 | $549,002 |
| Change in control and involuntary termination | $1,211,280 | $1,254,499 | $66,453 | $2,532,232 |
Per the Potential Payments Upon Termination or Change in Control table in PROCEPT BioRobotics Corp's FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
PROCEPT BioRobotics’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Larry Wood | President & Chief Executive Officer | $16,783,853 |
| Reza Zadno | Former President & Chief Executive Officer | $6,766,276 |
| Kevin Waters · this page | EVP, Chief Financial Officer | $2,750,253 |
| Alaleh Nouri | EVP, Chief Legal Officer & Corporate Secretary | $2,277,894 |
| Hisham Shiblaq | Former EVP, Chief Commercial Officer | $1,964,740 |
Kevin Waters's compensation dossier, PROCEPT BioRobotics
You have read Kevin Waters's totals and holdings. The dossier adds each equity grant PROCEPT BioRobotics disclosed for Kevin Waters and PROCEPT BioRobotics's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full PROCEPT BioRobotics compensation record
free company briefThis page is one person within PROCEPT BioRobotics's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the PROCEPT BioRobotics proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order PROCEPT BioRobotics's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PROCEPT BioRobotics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order PRCT
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.